These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22363018)

  • 1. Polyunsaturated fatty acids and peripheral artery disease.
    Grenon SM; Hughes-Fulford M; Rapp J; Conte MS
    Vasc Med; 2012 Feb; 17(1):51-63. PubMed ID: 22363018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral Artery Disease Is Associated with a Deficiency of Erythrocyte Membrane n-3 Polyunsaturated Fatty Acids.
    Ramirez JL; Zahner GJ; Spaulding KA; Khetani SA; Hills NK; Gasper WJ; Harris WS; Cohen BE; Grenon SM
    Lipids; 2019 Apr; 54(4):211-219. PubMed ID: 30883776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Siscovick DS; Barringer TA; Fretts AM; Wu JH; Lichtenstein AH; Costello RB; Kris-Etherton PM; Jacobson TA; Engler MB; Alger HM; Appel LJ; Mozaffarian D;
    Circulation; 2017 Apr; 135(15):e867-e884. PubMed ID: 28289069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
    Russo GL
    Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
    Schaller MS; Chen M; Colas RA; Sorrentino TA; Lazar AA; Grenon SM; Dalli J; Conte MS
    J Am Heart Assoc; 2020 Aug; 9(15):e016113. PubMed ID: 32696697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia.
    Akter K; Gallo DA; Martin SA; Myronyuk N; Roberts RT; Stercula K; Raffa RB
    J Clin Pharm Ther; 2012 Apr; 37(2):132-9. PubMed ID: 21501206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?
    Kromhout D; Yasuda S; Geleijnse JM; Shimokawa H
    Eur Heart J; 2012 Feb; 33(4):436-43. PubMed ID: 21933782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Diseases and Marine Oils: A Focus on Omega-3 Polyunsaturated Fatty Acids and Polar Lipids.
    Caffrey C; Leamy A; O'Sullivan E; Zabetakis I; Lordan R; Nasopoulou C
    Mar Drugs; 2023 Oct; 21(11):. PubMed ID: 37999373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Polyunsaturated Fatty Acids: Versatile Roles in Blood Pressure Regulation.
    Wang H; Li Q; Zhu Y; Zhang X
    Antioxid Redox Signal; 2021 Apr; 34(10):800-810. PubMed ID: 32349540
    [No Abstract]   [Full Text] [Related]  

  • 10. Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.
    Tutor A; O'Keefe EL; Lavie CJ; Elagizi A; Milani R; O'Keefe J
    Prog Cardiovasc Dis; 2024; 84():19-26. PubMed ID: 38547956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer.
    Bagga D; Capone S; Wang HJ; Heber D; Lill M; Chap L; Glaspy JA
    J Natl Cancer Inst; 1997 Aug; 89(15):1123-31. PubMed ID: 9262250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques.
    Calder PC; Yaqoob P
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):28-37. PubMed ID: 20196967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic role of n-3 polyunsaturated fatty acids: relationship to human disease.
    Kelly FJ
    Comp Biochem Physiol A Comp Physiol; 1991; 98(3-4):581-5. PubMed ID: 1674464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of omega-3 polyunsaturated fatty acids in cardiovascular health.
    Barrett SJ
    Altern Ther Health Med; 2013; 19 Suppl 1():26-30. PubMed ID: 23981464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fishing for brain power?
    King C; Fewtrell M
    Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F4-6. PubMed ID: 18156446
    [No Abstract]   [Full Text] [Related]  

  • 17. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored.
    Calder PC
    Clin Sci (Lond); 2004 Jul; 107(1):1-11. PubMed ID: 15132735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 Fatty Acids and Cardiovascular Disease Prevention.
    Tomdio A; Ritchie M; Miller AC
    Am Fam Physician; 2019 Aug; 100(4):209-210. PubMed ID: 31414778
    [No Abstract]   [Full Text] [Related]  

  • 19. Omega-6 polyunsaturated fatty acids: is a broad cholesterol-lowering health claim appropriate?
    Bazinet RP; Chu MW
    CMAJ; 2014 Apr; 186(6):434-9. PubMed ID: 24218530
    [No Abstract]   [Full Text] [Related]  

  • 20. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
    Cao Y; Lu L; Liang J; Liu M; Li X; Sun R; Zheng Y; Zhang P
    Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.